Workflow
Passive Foreign Investment Company (PFIC)
icon
Search documents
Aptose Biosciences(APTO) - Prospectus
2024-08-02 01:43
Table of Contents As filed with the Securities and Exchange Commission on August 1, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 APTOSE BIOSCIENCES INC. (Exact Name of Registrant As Specified In Its Charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Canada 2836 98-1136802 Classification Code Number) (I.R.S. Employer Identification Number) 66 ...
Scinai Immunotherapeutics .(SCNI) - Prospectus(update)
2023-12-22 14:11
As filed with the Securities and Exchange Commission on December 22, 2023. Registration No. 333-275217 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Scinai Immunotherapeutics Ltd. (Exact Name of Registrant as Specified in Its Charter) Not Applicable (Translation of Registrant's name into English) State of Israel 2836 Not Applicable (State or Other Jurisdiction of Incorporation or Organization) (Prim ...
Aptose Biosciences(APTO) - Prospectus
2023-12-02 01:29
Table of Contents As filed with the Securities and Exchange Commission on December 1, 2023 Registration No. 333-________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 APTOSE BIOSCIENCES INC. (Exact Name of Registrant As Specified In Its Charter) (State or other jurisdiction of incorporation or organization) Canada 2836 98-1136802 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification ...
Scinai Immunotherapeutics .(SCNI) - Prospectus
2023-10-30 20:59
As filed with the Securities and Exchange Commission on October 30, 2023. Registration No. 333-_________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant's Principal Executive Offices) Puglisi & Associates 850 Library Avenue, Suite 204 Newark, Delaware +1 (302) 738-6680 Scinai Immunotherapeutics Ltd. (Exact Name of Registrant as Specif ...
NeuroSense Therapeutics(NRSN) - Prospectus(update)
2023-08-31 20:16
As filed with the Securities and Exchange Commission on August 31, 2023. Registration No. 333-273375 (Exact Name of Registrant as Specified in Its Charter) ____________________ Not Applicable (Translation of Registrant's name into English) | State of Israel | 2834 | Not Applicable | | --- | --- | --- | | (State or Other Jurisdiction of | (Primary Standard Industrial | (I.R.S. Employer | | Incorporation or Organization) | Classification Code Number) | Identification Number) | 11 HaMenofim Street, Building B ...
NeuroSense Therapeutics(NRSN) - Prospectus(update)
2023-08-14 20:16
As filed with the Securities and Exchange Commission on August 14, 2023. Registration No. 333-273375 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________ Amendment No. 1 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NeuroSense Therapeutics Ltd. (Exact Name of Registrant as Specified in Its Charter) ____________________ Not Applicable (Translation of Registrant's name into English) | State of Israel | 2834 | Not Applicable | | --- | --- | --- | | (St ...